Quantitative histological‐hemodynamic correlations in cirrhosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hepatology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24805PMID 22109744PMCID PMC3721182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is hydrophobia necessary for the hepatologist prescribing nonselective beta‐blockers in cirrhosis?

  2011cited by this paper
• Meta‐analysis: isosorbide‐mononitrate alone or with either beta‐blockers or endoscopic therapy for the management of oesophageal varices

  2010cited by this paper
• Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

  2010cited by this paper
• Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

  2010cited by this paper
• Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient

  2009cited by this paper
• Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

  2009cited by this paper
• Histological subclassification of cirrhosis based on histological–haemodynamic correlation

  2008cited by this paper
• Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis

  2007influential reference
• Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

  2007cited by this paper
• Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.

  2006cited by this paper
• Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

  2005cited by this paper
• The hepatic venous pressure gradient: Anything worth doing should be done right

  2004cited by this paper
• Sampling variability of liver fibrosis in chronic hepatitis C

  2003cited by this paper
• Diagnosis of Portal Hypertension: How and When

  2001cited by this paper
• Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C.

  2001cited by this paper
• Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

  2000cited by this paper
• Long‐term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies

  1997cited by this paper
• Correlations between sinusoidal pressure and liver morphology in cirrhosis.

  1994cited by this paper
• Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

  1985cited by this paper
• Increased blood flow through the portal system in cirrhotic rats.

  1984cited by this paper

• Iodine‐enhanced x‐ray phase‐contrast CT for three‐dimensional virtual histopathology evaluation of human cirrhosis

  2026cites this paper
• Preliminary quantitative assessment of liver and spleen MR imaging and elastography in clinically significant portal hypertension

  2026cites this paper
• Using intra-voxel incoherent motion MRI to dynamically evaluate the attenuating effects of donafenib combined with carvedilol in a thioacetamide-induced hepatic fibrosis rat model

  2025cites this paper
• X射线相衬CT在肝脏疾病三维微观结构解析中的应用进展（特邀）

  2025cites this paper
• The pathophysiological role of portal hypertension in metabolic dysfunction–associated steatotic liver disease

  2025cites this paper
• Vasomics of the liver

  2025cites this paper
• Sugar-coated bullets: Unveiling the enigmatic mystery ‘sweet arsenal’ in osteoarthritis

  2024cites this paper
• Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis

  2024cites this paper
• Enhancing Histology Detection in MASH Cirrhosis for Artificial Intelligence Pathology Platform by Expert Pathologist Training

  2024cites this paper
• Quantitative computed tomography‐based approaches for noninvasive diagnosis of portal hypertension in patients with cirrhosis

  2023cites this paper
• The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation

  2023cites this paper
• Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis

  2023cites this paper
• Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

  2022cites this paper
• MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension

  2022cites this paper
• Liver fibrosis quantification

  2022cites this paper
• Evaluation of hepatic hemodynamics (hepatic venous pressure gradient) during right heart catheterization: a comprehensive review.

  2022cites this paper
• Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients

  2021cites this paper
• Iterative reconstruction algorithm based on discriminant adaptive-weighted TV regularization for fibrous biological tissues using in-line X-ray phase-contrast imaging.

  2021cites this paper
• Thick Fibrous Septa on Liver Biopsy Specimens Predict the Development of Decompensation in Patients With Compensated Cirrhosis.

  2021cites this paper
• A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis

  2021influential citation
• Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): An International Multicenter Study

  2021cites this paper
• Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure

  2021cites this paper
• Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma

  2020cites this paper
• Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.

  2020cites this paper
• Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma

  2020cites this paper
• Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

  2020cites this paper
• Quantitative evaluation of hepatic integrin αvβ3 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis

  2020cites this paper
• Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis

  2020cites this paper
• Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?

  2019cites this paper
• Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats.

  2019cites this paper
• A new in-line X-ray phase-contrast computed tomography reconstruction algorithm based on adaptive-weighted anisotropic TpV regularization for insufficient data.

  2019cites this paper
• Molecular prognosis in liver cirrhosis

  2019cites this paper
• Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis.

  2019cites this paper
• Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.

  2019cites this paper
• Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT

  2019cites this paper
• Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension

  2019cites this paper
• Relationship Between Portal HTN and Cirrhosis as a Cause for Diabetes

  2019cites this paper
• A critical review of endpoints for non-cirrhotic NASH therapeutic trials.

  2018cites this paper
• Hepatic Venous Pressure Measurement and Other Diagnostic Hepatic Hemodynamic Techniques

  2018cites this paper
• Portal Hypertension in Cirrhosis

  2018cites this paper
• Cirrhosis and Portal Hypertension: Staging and Prognosis

  2018cites this paper
• Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.

  2018cites this paper
• No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

  2018cites this paper
• Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients

  2018cites this paper
• Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis

  2017cites this paper
• Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling

  2017cites this paper
• Prospective evaluation of liver and spleen stiffness by transient and point shear wave elastography: surrogate markers of fibrosis and clinically significant portal hypertension in cirrhosis

  2017cites this paper
• Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease

  2017cites this paper
• Relación entre el factor de crecimiento hepático y el estadio de la cirrosis

  2017cites this paper
• Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial

  2017cites this paper
• Clinical states of cirrhosis and competing risks.

  2017cites this paper
• Evaluación de la hipertensión portal clínicamente significativa mediante elastografía hepática

  2016cites this paper
• Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

  2016cites this paper
• Quantitative morphometric and immunohistochemical analysis and their correlates in cirrhosis – A study on explant livers

  2016cites this paper
• Antifibrotics in chronic liver disease: tractable targets and translational challenges.

  2016cites this paper
• LIVER CIRRHOSIS: NEW CONCEPTS

  2016cites this paper
• Advances in the treatment of portal hypertension in cirrhosis

  2016cites this paper
• Digital image analysis in liver fibrosis: basic requirements and clinical implementation

  2016cites this paper
• Correlations of portal pressure in post‐cholecystectomy benign biliary stricture

  2015cites this paper
• Cirrhotic Multiorgan Syndrome

  2015cites this paper
• Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS

  2015influential citation
• Quantitative assessment of liver fibrosis by digital image analysis: Relationship to Ishak staging and elasticity by shear‐wave elastography

  2015cites this paper
• Resolution of Liver Fibrosis: Basic Mechanisms and Clinical Relevance

  2015cites this paper
• Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis

  2015cites this paper
• Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.

  2015cites this paper
• Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014

  2015cites this paper
• Angiogenesis: a new surrogate histopathological marker is capable of differentiating between mild and significant portal hypertension.

  2015cites this paper
• Molecular prognostic prediction in liver cirrhosis.

  2015cites this paper
• New methods to detect liver fibrosis severity and predict clinical outcomes in chronic hepatitis C infection

  2015cites this paper
• 4. Histology/pathology

  2015cites this paper
• Natural History of Cirrhosis

  2015cites this paper
• Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis.

  2014cites this paper
• Beyond a Broken Heart: Circulatory Dysfunction in the Failing Fontan

  2014cites this paper
• A new technique to improve the mechanical and biological performance of ultra high molecular weight polyethylene using a nylon coating.

  2014cites this paper
• Replacing a crystal ball with a calculator in predicting liver disease outcomes.

  2014cites this paper
• Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

  2014cites this paper
• qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

  2014cites this paper
• Computer-aided-diagnosis of liver fibrosis using non-linear optics microscopy

  2014influential citation
• Role of magnetic resonance elastography in compensated and decompensated liver disease.

  2014cites this paper
• Hydrogels with differential and patterned mechanics to study stiffness-mediated myofibroblastic differentiation of hepatic stellate cells.

  2014cites this paper
• Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.

  2013cites this paper
• Reg ional me tabolic liv er func tion measur ed in pat ients with cirrhosis by 2-( 18 F)fluoro-2-deo xy- D-ga lactose PET/ CT

  2013cites this paper
• Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment?

  2013cites this paper
• Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome

  2013cites this paper
• Cirrhosis histology and Laennec staging system correlate with high portal pressure

  2013influential citation
• Assessing portal hypertension in liver diseases

  2013cites this paper
• Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers

  2013cites this paper
• Cirrhosis Regression and Subclassification.

  2013cites this paper
• Salvianolic Acid B Reducing Portal Hypertension Depends on Macrophages in Isolated Portal Perfused Rat Livers with Chronic Hepatitis

  2012influential citation
• Rethinking the Role of Liver Biopsy in the Era of Personalized Medicine

  2012cites this paper